Ultimate biodegradability and ecotoxicity of orally administered antidiabetic drugs

被引:39
|
作者
Markiewicz, Marta [1 ]
Jungnickel, Christian [2 ]
Stolte, Stefan [1 ,3 ]
Bialk-Bielinska, Anna [3 ]
Kumirska, Jolanta [3 ]
Mrozik, Wojciech [4 ,5 ]
机构
[1] Univ Bremen, UFT Ctr Environm Res & Technol, Leobener Str, D-28359 Bremen, Germany
[2] Gdansk Univ Technol, Fac Chem, Dept Colloid & Lipid Sci, Ul Narutowicza 11-12, PL-80233 Gdansk, Poland
[3] Univ Gdansk, Fac Chem, Dept Environm Anal, Ul W Stwosza 63, PL-80308 Gdansk, Poland
[4] Newcastle Univ, Sch Civil Engn & Geosci, Cassie Bldg, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[5] Med Univ Gdansk, Fac Pharm, Dept Inorgan Chem, Al Hallera 107, PL-80416 Gdansk, Poland
基金
英国工程与自然科学研究理事会;
关键词
Biodegradation; Ecotoxicity; Pharmaceuticals; Antidiabetic drugs; Sulphonamides; TRANSFORMATION PRODUCT GUANYLUREA; HUMAN PHARMACEUTICALS; MASS-SPECTROMETRY; WASTE-WATER; METFORMIN; IDENTIFICATION; DEGRADATION;
D O I
10.1016/j.jhazmat.2017.03.030
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Hypoglycaemic pharmaceuticals are recently more and more frequently detected in the environment. In our previous study, we have shown that even though many of them undergo significant primary degradation some are transformed to stable products or undergo such transformation that a large part of the structure is still preserved. One of the main routes of elimination from wastewaters or surface waters is biodegradation and a lack thereof leads to accumulation in the environment. Within this work we tested the ultimate biodegradability of six oral antidiabetics: metformin and its main metabolite guanylurea, acarbose, glibenclamide, gliclazide, glimepiride and repaglinide. We also compared the experimental results obtained in this and accompanying work with models designed to predict biodegradability and showed that these models are only moderately successful. Additionally, we examined these compounds in acute Daphnia magna test to check if they might pose an ecotoxicological threat. Combining the results of biodegradability and toxicity tests allows a preliminary assessment of their potential environmental impact. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:154 / 161
页数:8
相关论文
共 50 条
  • [31] Biodegradability and ecotoxicity of amine oxide based surfactants
    Garcia, M. T.
    Campos, E.
    Ribosa, I.
    CHEMOSPHERE, 2007, 69 (10) : 1574 - 1578
  • [32] ROLE OF MODEL SYSTEMS IN ASSESSING BIOAVAILABILITY OF ORALLY-ADMINISTERED DRUGS
    SWARBRICK, J
    DRUG DEVELOPMENT COMMUNICATIONS, 1976, 2 (06): : 439 - 451
  • [33] Improving the prediction of the brain disposition for orally administered drugs using BDDCS
    Broccatelli, Fabio
    Larregieu, Caroline A.
    Cruciani, Gabriele
    Oprea, Tudor I.
    Benet, Leslie Z.
    ADVANCED DRUG DELIVERY REVIEWS, 2012, 64 (01) : 95 - 109
  • [34] NUMERICAL TAXONOMY OF BACILLUS ISOLATED FROM ORALLY-ADMINISTERED DRUGS
    GIL, MC
    DELAROSA, MC
    MOSSO, MA
    ARRIBAS, MLG
    JOURNAL OF APPLIED BACTERIOLOGY, 1986, 61 (04): : 347 - 356
  • [35] Evaluating physiochemical properties of FDA-approved orally administered drugs
    Reese, Tanner C.
    Devineni, Anvita
    Smith, Tristan
    Lalami, Ismail
    Ahn, Jung-Mo
    Raj, Ganesh V.
    EXPERT OPINION ON DRUG DISCOVERY, 2024, 19 (02) : 225 - 238
  • [36] Pre-systemic metabolism of orally administered drugs and strategies to overcome it
    de Sousa, Irene Pereira
    Bernkop-Schnuerch, Andreas
    JOURNAL OF CONTROLLED RELEASE, 2014, 192 : 301 - 309
  • [37] CLINICAL EVALUATION OF ANTIPRURITIC DRUGS - CONSIDERATION OF ORALLY OR PARENTERALLY ADMINISTERED AGENTS
    CORMIA, FE
    DOUGHERTY, JW
    ARCHIVES OF DERMATOLOGY, 1959, 79 (02) : 172 - 178
  • [38] Glucuronidation of orally administered drugs and the value of nanocarriers in strategies for its overcome
    Hervieu, Laura
    Groo, Anne-Claire
    Bellien, Jeremy
    Guerrot, Dominique
    Malzert-Freon, Aurelie
    PHARMACOLOGY & THERAPEUTICS, 2025, 266
  • [39] Clinical Pharmacokinetics of Drugs in Patients with Heart Failure: An Update (Part 2, Drugs Administered Orally)
    Ryuichi Ogawa
    Joan M. Stachnik
    Hirotoshi Echizen
    Clinical Pharmacokinetics, 2014, 53 : 1083 - 1114
  • [40] Clinical Pharmacokinetics of Drugs in Patients with Heart Failure: An Update (Part 2, Drugs Administered Orally)
    Ogawa, Ryuichi
    Stachnik, Joan M.
    Echizen, Hirotoshi
    CLINICAL PHARMACOKINETICS, 2014, 53 (12) : 1083 - 1114